http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-107739-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48f7255434903fd551db1ede1eef9aac |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 |
| filingDate | 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa1d9b9ec65eaa590b92edf73dcbe049 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08c2d82f3faccfde101dfb86db1bf98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3eec17353fa2e5f19cd5db57e7d90e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf1a567418be2e50799e36f3909dd26 |
| publicationDate | 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PT-107739-B |
| titleOfInvention | COMPOSITE FORMULATION FOR TREATMENT OF INFECTIONS AND THEIR PRODUCTION METHOD |
| abstract | BACKGROUND OF THE INVENTION This invention relates to the preparation of antimicrobially active compounds of polyesters and oligo- or polyoxazole with antimicrobial activity (POX) through a process of atomization assisted by carbon dioxide compressed to the potential for administration and controlled release of the lungs. DETAILS FOR THE FIRST TIME THE INCORPORATION OF AN OLIGOMER / POLYMER DERIVED FROM OXAZOLINE WITH ANTIMICROBIAL ACTIVITY OF LONG SPECTRUM, BIOCOMPATIBLE AND BIODEGRADABLE, IN A FORMULATION OF COMPOSITE PARTICLES FOR THERAPY IN THE LUNG CONTAINING CHOLESTEROL, ENDOGENOUS LUNG. THIS FORMULATION RESULTS UNEXPECTEDLY IN A POW WITHOUT PRACTICALLY STATIC ELECTRICITY, WHICH ALLOWED TO HIS HUGE POTENTIAL OF USE IN THE TREATMENT OF LUNG INFECTIONS, FACILITATES THE POWDER COLLECTION OF THE INSTALLATION, ACTION GUE SOLVES A GREAT TECHNICAL PROBLEM OF THE ATOMIZATION, AND DOSES ISSUED OF THE CAPSULES OF THE VERY HIGH DPI WITH THE CONSECUTIVE ADVANTAGES AT THE LEVEL OF USE OF FORMULATION IN THERAPEUTIC USE. |
| priorityDate | 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.